Browse by Title

Type here to filter the list

W
What Do We Need to Optimize Trial Design in Neonatology & Pediatrics: Role of Industry, Academia & Regulatory (6)
Favorite

6
What is the New Collaboration With ACCP All About? (4)
Favorite

Craig W. Hendrix, MD, DABCP – Johns Hopkins Univ School of Medicine and Chairman, American Board of Clinical Pharmacology ### 1827468###Faculty###Professor of Medicine (Clinical Pharmacology)###Johns Hopkins Univ School of Medicine and Chairman, American Board of Clinical Pharmacology###
Faculty: Craig W. Hendrix, MD, DABCP – Johns Hopkins Univ School of Medicine and Chairman, American Board of Clinical Pharmacology
### 4
Why & How Does a Clinical Pharmacologist Achieve Board Certification? (3)
Favorite

Lionel D. Lewis, MA, MBBCh, MD – American Board of Clinical Pharmacology ### 1948972###Faculty###Professor of Medicine/Pharmacology & Toxicology, The Geisel School of Medicine at Dartmouth, Executive Director###American Board of Clinical Pharmacology###
Faculty: Lionel D. Lewis, MA, MBBCh, MD – American Board of Clinical Pharmacology
### 3
Why an American Board of Clinical Pharmacology? (1)
Favorite

Lionel D. Lewis, MA, MBBCh, MD – American Board of Clinical Pharmacology ### 1948972###Faculty###Professor of Medicine/Pharmacology & Toxicology, The Geisel School of Medicine at Dartmouth, Executive Director###American Board of Clinical Pharmacology###
Faculty: Lionel D. Lewis, MA, MBBCh, MD – American Board of Clinical Pharmacology
### 1
Why Are FDA-approved Drug Labels Pertaining to Food-Drug Interactions Essential to the Advancement of Therapeutic Optimization of Oral Cancer Drugs? (4)
Favorite

Lawrence Lesko, PhD – Univ of Florida Coll of Pharmacy ### 1827452###Faculty###Clinical Professor & Director, Ctr for Pharmacometrics & Systems Pharmacology###Univ of Florida Coll of Pharmacy###
Faculty: Lawrence Lesko, PhD – Univ of Florida Coll of Pharmacy
### 4